Search results for : tm - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Search Results for: tm

Drugs (5)
Celllines ( 4)
Genetic Features (1)

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
CP466722	CP-466722, CP 466722, 1080622-86-1	ATM	Genome integrity	44551660	GDSC1	915	MGH
KU-55933	KU55933	ATM	Genome integrity	5278396	GDSC1	931	SANGER
KU-55933	KU55933	ATM	Genome integrity	5278396	GDSC2	955	SANGER
KU-60019		ATM	Genome integrity		GDSC1	925	SANGER
torin2		MTOR, ATM, ATR, DNAPK	PI3K/MTOR signaling		GDSC1	131	SANGER

Name	Cell Model Passport Link	COSMIC ID	Tissue	Tissue sub-type
LCLC-97TM1	SIDM00344	946361	UNCLASSIFIED	Lung
LCLC-97TM1	SIDM00344	946361	UNCLASSIFIED	Lung
TMK-1	SIDM00040	1299069	STAD	Digestive system
TMK-1	SIDM00040	1299069	STAD	Digestive system

Feature Name	Feature Type
ATM_mut	coding variant

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).